Cemdisiran, terminal sugar modification-
[(2S,4R)-1-[12-[[1,3-bis[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]-2-[[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]methyl]propan-2-yl]amino]-12-oxododecanoyl]-4-hydroxypyrrolidin-2-yl]methyl dihydrogen phosphate
Molecular Identity
Cemdisiran, terminal sugar modification-
[(2S,4R)-1-[12-[[1,3-bis[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]-2-[[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]methyl]propan-2-yl]amino]-12-oxododecanoyl]-4-hydroxypyrrolidin-2-yl]methyl dihydrogen phosphate
PubChem CID: 126480325
2D Structure
Properties
C78H140N11O34P
Molecular Formula
1807.00
Molecular Weight
g/mol
1805.9302
Exact Mass
Da
-8
XLogP
Drug-like (Lipinski: < 5)
663
TPSA
May have limited oral absorption
22
H-Bond Donors
34
H-Bond Acceptors
2950
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(18)
Cemdisiran, terminal sugar modification-1436858-07-9CQQ59545BVUNII-CQQ59545BVInclisiran, terminal sugar modification-RefChem:200106Cemdisiran1639264-46-2orb1982842orb3032967SCHEMBL31244579GLXC-26019EX-A8119Cemdisiran, terminal sugar modificationDA-62205
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Cemdisiran, terminal sugar modification-
Loading drug network...